Filing Flows › AstraZeneca (AZN) › Free cash flow
AstraZeneca (AZN) free cash flow by quarter
AstraZeneca's free cash flow was $5.1B in Q3 2026 (third quarter 2026), +33% from Q2 2026. Over the last 4 quarters it ranged from $3.8B (Q1 2026) to $5.5B (Q3 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $5.1B | +33% | -8% |
| Q2 2026 | $3.8B | +1% | — |
| Q1 2026 | $3.8B | -32% | — |
| Q3 2025 | $5.5B | — | — |
Q3 2026 at a glance
AstraZeneca, Q3 2026: revenue $16.2B (+7% year over year), operating margin 27.1%, net earnings $3.1B, operating cash flow $5.8B. The chart follows the revenue to costs, profit and cash.
Questions
What is AstraZeneca's free cash flow?
AstraZeneca's free cash flow was $5.1B in Q3 2026 (third quarter 2026), +33% from Q2 2026.
How has AstraZeneca's free cash flow changed?
Over the last 4 quarters it ranged from $3.8B (Q1 2026) to $5.5B (Q3 2025).